White papers and other resources

Scientific journals

Conference posters

November 3, 2023
SITC 2023
Profiling microsatellite instability using RNA sequencing data
September 21, 2023
5th Annual RAS-Targeted Drug Development Summit 2023
ResponderID™ KRAS: Biology-Driven Machine Learning to Personalize KRAS Inhibitor Therapeutics
June 13, 2023
EACR 2023
Evaluation of a KRAS gene expression signature in lung cancer
April 17, 2023
AACR 2023
The Xerna™ TME Panel potentially predicts response to a combination of the TLR9 agonist vidutolimod and PD-1 inhibitor pembrolizumab in metastatic melanomas with prior anti-PD-1 treatment
April 5, 2023
HubXchange 2023
ResponderID™: The Biology-First Machine Learning Platform for Biomarker Discovery
November 30, 2022
SITC 2022
Xerna tumor microenvironment subtypes as a biomarker in lung cancer patients
September 30, 2022
ESMO 2022
Predicting benefit from maintenance durvalumab after first-line chemotherapy (1L CTx) in oesophagogastric adenocarcinoma (OGA) using a novel tumour microenvironment (TME) RNA assay
April 11, 2022
AACR 2022
Xerna™ TME Panel: A pan-cancer RNA-based investigational assay designed to predict patient response to angiogenic- and immune-targeted therapies

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release →

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release → Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release →

This website uses cookies and third party services. Read More Accept Reject